Literature DB >> 11413384

Equine rhinitis A virus: structural proteins and immune response.

Carol A Hartley1, Nino Ficorilli1, Kemperly Dynon1, Heidi E Drummer2, Jin-An Huang1, Michael J Studdert1.   

Abstract

Equine rhinitis A virus (ERAV) is a picornavirus that has been reclassified as a member of the Aphthovirus genus because of its resemblance to foot-and-mouth disease virus at the level of nucleotide sequence and overall genomic structure. The N-terminal amino acid sequence of three of the four capsid proteins of ERAV was determined and showed that the proteolytic cleavage sites within the precursor P1 polypeptide occur exactly as those predicted for an aphthovirus-like 3C protease, which generates the capsid proteins VP1 and VP3. However, the autocatalytic cleavage site between VP4 and VP2, which is independent of 3C protease cleavage, was different from that predicted previously. ERAV.393/76 antisera from horses and rabbits showed different reactivity to the viral structural proteins in both serum neutralization assays and Western blots. High neutralizing antibody titres appeared to correlate with strong reactivity to VP1 in Western blots.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11413384     DOI: 10.1099/0022-1317-82-7-1725

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Several recombinant capsid proteins of equine rhinitis a virus show potential as diagnostic antigens.

Authors:  Fan Li; Rachel A Stevenson; Brendan S Crabb; Michael J Studdert; Carol A Hartley
Journal:  Clin Diagn Lab Immunol       Date:  2005-06

2.  Evidence that Equine rhinitis A virus VP1 is a target of neutralizing antibodies and participates directly in receptor binding.

Authors:  S Warner; C A Hartley; R A Stevenson; N Ficorilli; A Varrasso; M J Studdert; B S Crabb
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  Sequence conservation and antigenic variation of the structural proteins of equine rhinitis A virus.

Authors:  A Varrasso; H E Drummer; J A Huang; R A Stevenson; N Ficorilli; M J Studdert; C A Hartley
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

4.  Genomic analysis of a Canadian equine rhinitis A virus reveals low diversity among field isolates.

Authors:  Andrés Diaz-Méndez; Laurent Viel; Patricia Shewen; Eva Nagy
Journal:  Virus Genes       Date:  2012-11-24       Impact factor: 2.332

Review 5.  Assessment of the viral safety of antivenoms fractionated from equine plasma.

Authors:  Thierry Burnouf; Elwyn Griffiths; Ana Padilla; Salwa Seddik; Marco Antonio Stephano; José-María Gutiérrez
Journal:  Biologicals       Date:  2004-09       Impact factor: 1.856

6.  Equine rhinitis A virus and its low pH empty particle: clues towards an aphthovirus entry mechanism?

Authors:  Tobias J Tuthill; Karl Harlos; Thomas S Walter; Nick J Knowles; Elisabetta Groppelli; David J Rowlands; David I Stuart; Elizabeth E Fry
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

7.  Development of one-step TaqMan® real-time reverse transcription-PCR and conventional reverse transcription-PCR assays for the detection of equine rhinitis A and B viruses.

Authors:  Zhengchun Lu; Peter J Timoney; Jena White; Udeni Br Balasuriya
Journal:  BMC Vet Res       Date:  2012-07-25       Impact factor: 2.741

8.  Equine rhinitis B viruses in horse fecal samples from the Middle East.

Authors:  Patrick C Y Woo; Susanna K P Lau; Garnet K Y Choi; Yi Huang; Renate Wernery; Sunitha Joseph; Emily Y M Wong; Shyna K Elizabeth; Nissy Annie Georgy Patteril; Tong Li; Ulrich Wernery; Kwok-Yung Yuen
Journal:  Virol J       Date:  2016-06-07       Impact factor: 4.099

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.